Dabrafenib/trametinibExacerbation of pre-existing multiple sclerosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2030卷 / 1期

关键词：

D O I：

10.1007/s40278-024-68957-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：156 / 156

相关论文

共 50 条

[1] BupivacaineTrigger of pre-existing multiple sclerosis: case report
Reactions Weekly, 2017, 1666 (1) : 66 - 66
[2] Dabrafenib/trametinibProgression of a pre-existing adenocarcinoma: case report
Reactions Weekly, 2015, 1577 (1) : 96 - 96
[3] Dabrafenib/trametinibExacerbation of Kaposi sarcoma: case report
Reactions Weekly, 2024, 2032 (1) : 146 - 146
[4] CeftriaxoneWorsening of pre-existing hyperbilirubinaemia: case report
Reactions Weekly, 2022, 1936 (1) : 141 - 141
[5] OxytocinWorsening of pre-existing hyponatremia: case report
Reactions Weekly, 2021, 1862 (1) : 382 - 382
[6] MetronidazoleExacerbation of pre-existing mania: case report
Reactions Weekly, 2022, 1926 (1) : 308 - 308
[7] CalcitriolAggravation of pre-existing hypercalcaemia: case report
Reactions Weekly, 2019, 1757 (1) : 73 - 73
[8] Multiple drugsWorsening of pre-existing carcinoid syndrome and lack of efficacy: case report
Reactions Weekly, 2022, 1908 (1) : 430 - 430
[9] LenograstimFlare of pre-existing IgA glomerulonephritis: case report
Reactions Weekly, 2021, 1839 (1) : 167 - 167
[10] RituximabWorsening of pre-existing peripheral neuropathy: case report
Reactions Weekly, 2016, 1592 (1) : 189 - 189

← 1 2 3 4 5 →